- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03059394
Validation of Rehab Assessments in Myositis Patients
Validation of Manual Muscle Testing and the Myositis Activity Profile Assessments in Patients With Inflammatory Myositis
Study Overview
Detailed Description
This study evaluates the validity and reliability of two health related instruments that assess disease relevant functions and disabilities in patients with IM: the manual muscle testing 8 (MMT8) and the myositis activity profile (MAP). This study is needed to determine the psychometric properties of these two assessments. Provided that both the MMT8 and the MAP show good psychometric properties, these assessments could be used in the rehabilitation process and intervention programs of patients with IM to determine progress in muscle strength and activity in daily life.
Methodology: Reliability (Test re-test study and validity (cross sectional study) of a short form of MMT 8 and a questionnaire to assess difficulties in activities of daily life (MAP) in myositis patients.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Zurich, Switzerland, 8091
- University Hospital Zurich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
- Patients with diagnosed inflammatory myopathy
- Age and gender matched controls
Description
Inclusion Criteria:
- Diagnosis of polymyositis or dermatomyositis or inflammatory myositis associated disorders (e.g. Scleroderma, Systematic lupus erythematosus, Sjögren's syndrome)
- Age over 18
- Sufficiently understanding of German language
- able to understand and follow verbal and written instructions
- signed informed consent to participate in the study
Exclusion Criteria:
- Diagnosis of inclusion body myositis
- Pulmonary hypertension
- Osteoporosis
- Severe cardiovascular and/or pulmonary disease
- Pain syndrome
- Paresis
Inclusion Criteria aged and gender matched healthy controls (Systematic lupus erythematosus, Sjögren's syndrome)
- Age over 18
- Sufficiently understanding of German language
- able to understand and follow verbal and written instructions
- signed informed consent to participate in the study
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Manual Muscle Testing 8 (MMT8)
Time Frame: 15 minutes
|
The strength of 8 Muscle groups is tested in a defined position and rewarded with a score varying from 0 (No visible movement) to 10 (holds test position against strong pressure) and summed for a potential score from 0-80.
|
15 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantitative Muscle Testing
Time Frame: 15 Minutes
|
Hand Held Dynamometer in Newton
|
15 Minutes
|
|
Functional Index 2
Time Frame: 30 minutes
|
Evaluates muscle endurance of the upper & lower extremity and neck flexors movements: amount of repetitions.
|
30 minutes
|
|
Functional Test Battery (FTB): Test 1 Self-Performed Physical Performance Test.
Time Frame: Total FTB: 1 1/4 hours
|
Time in seconds to get up and sit down 5 times from a chair.
|
Total FTB: 1 1/4 hours
|
|
Functional Test Battery (FTB): Balance Test
Time Frame: Total FTB: 1 1/4 hours
|
Time in seconds (max 10 sec.) 1) balance feet together, 2) semi-tandem, 3) full-tandem stand.
|
Total FTB: 1 1/4 hours
|
|
Functional Test Battery ( FTB): Walk test ( 4 m)
Time Frame: Total FTB: 1 1/4 hours
|
Time in sec.
|
Total FTB: 1 1/4 hours
|
|
Functional Test Battery ( FTB): 1 leg stand
Time Frame: Total FTB: 1 1/4 hours
|
Time in sec.
|
Total FTB: 1 1/4 hours
|
|
Functional Test Battery ( FTB): Grip ability Test
Time Frame: Total FTB: 1 1/4 hours
|
Time in sec. (max 60 sec.)
|
Total FTB: 1 1/4 hours
|
|
Functional Test Battery ( FTB): Jamar grip test
Time Frame: Total FTB: 1 1/4 hours
|
Strength in Kg.
|
Total FTB: 1 1/4 hours
|
|
Functional Test Battery ( FTB): Pile Test
Time Frame: Total FTB: 1 1/4 hours
|
Work = Joule & Performance = Watt
|
Total FTB: 1 1/4 hours
|
|
Functional Test Battery ( FTB): 6 Minute walk-test
Time Frame: Total FTB: 1 1/4 hours
|
Meters during 6 minutes
|
Total FTB: 1 1/4 hours
|
|
Modified Myositis Activity Profile
Time Frame: 30 Minutes
|
34 item Questionnaire
|
30 Minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Baschung Pfister Pierrette, MPH, University of Zurich
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014-0022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myositis
-
Novartis PharmaceuticalsCompletedSporadic Inclusion Body Myositis (sIBM)United States
-
Austin Neuromuscular CenterRegeneron PharmaceuticalsRecruitingIdiopathic Inflammatory Myopathies | Sporadic Inclusion Body Myositis (sIBM)United States
-
Abcuro, Inc.Active, not recruitingInclusion Body Myositis (IBM)United States, Australia
-
University of Southern DenmarkOdense University HospitalCompleted
-
Institut National de la Santé Et de la Recherche...CompletedInclusion Body Myositis (IBM)France
-
University of Kansas Medical CenterCompletedInclusion Body Myositis | Sporadic Inclusion Body MyositisUnited States
-
Novartis PharmaceuticalsCompletedSporadic Inclusion Body MyositisUnited States
-
La-ser Europe LimitedUnknownSporadic Inclusion Body Myositis
-
Manchester Metropolitan UniversityNorthern Care Alliance NHS Foundation Trust; Myositis UK; NeuroMuscular Centre...Not yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingInflammatory Myositis | Idiopathic Inflammatory Myositis | Drug-induced Inflammatory MyositisFrance
Clinical Trials on Non intervention study
-
Roswell Park Cancer InstituteUniversity at BuffaloRecruitingSarcoma | Childhood Sarcoma of Soft TissueUnited States
-
Pro-Lab DiagnosticsUnknownFetal Membranes, Premature RuptureUnited States
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruitingArtificial Intelligence | Medicine, Chinese Traditional
-
Puerta de Hierro University HospitalParc Taulí Hospital UniversitariRecruiting
-
GlaxoSmithKlineCompleted
-
Shanghai Chest HospitalNot yet recruiting
-
Tianjin Happy Life Technology Co., Ltd.Unknown
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingHigh-Risk Acute Myeloid Leukemia | Relapse And/or Refractory AML
-
Ottawa Hospital Research InstituteThe Physicians' Services Incorporated FoundationCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedMolar Incisor HypomineralisationUnited Kingdom